Elsevier

Gynecologic Oncology

Volume 129, Issue 3, June 2013, Pages 443-444
Gynecologic Oncology

Editorial
Opportunistic salpingectomy for women at low risk for development of ovarian carcinoma: The time has come

https://doi.org/10.1016/j.ygyno.2013.04.021Get rights and content

Section snippets

Conflict of interest statement

The authors declare that there are no conflicts of interest.

References (19)

  • S. Salvador et al.

    Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of ovarian and fallopian tube mucosal serous carcinoma

    Gynecol Oncol

    (2008)
  • C. Westhoff et al.

    Tubal sterilization: focus on the U.S. experience

    Fertil Steril

    (2000)
  • M. Morelli et al.

    Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere

    Gynecol Oncol

    (2013)
  • T.J. Colgan et al.

    Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status

    Am J Surg Pathol

    (2001)
  • J.M. Piek et al.

    Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer

    J Pathol

    (2001)
  • F. Medeiros et al.

    Am J Surg Pathol

    (2006)
  • D.W. Kindelberger et al.

    Am J Surg Pathol

    (2007)
  • S. Tang et al.

    Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases

    Int J Gynecol Pathol

    (2012)
  • J.W. Carlson et al.

    Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention

    J Clin Oncol

    (2008)
There are more references available in the full text version of this article.

Cited by (20)

  • Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention

    2017, Gynecologic Oncology
    Citation Excerpt :

    The risk-reducing benefit likely extends beyond the already known risk reduction from tubal ligation [7–11]. This evidence has led gynecologists to perform opportunistic salpingectomies at the time of hysterectomy or tubal surgery for permanent contraception, and many major gynecologic societies in the United States and Canada support this practice change [12,13]. A recent study evaluating hysterectomy practices in a large health system revealed a significant increase in rates of hysterectomies being performed with salpingectomy (14.7% in 2011 to 72.7% in 2014, p < 0.001) [14].

  • PAX8 expression in ovarian surface epithelial cells

    2015, Human Pathology
    Citation Excerpt :

    More recent evidence indicates that HGSOCs can originate from epithelial cells lining the fallopian tube fimbriae, through a precursor lesion termed serous tubal intraepithelial carcinoma (STIC). STICs are associated with 20% to 60% of sporadic HGSOCs [5–8], raising the possibility that the remaining 40% to 80% of HGSOCs may arise from an alternative cell of origin. Several studies have shown that paired box 8 (PAX8) is highly expressed in most HGSOCs [9–14], suggesting that overexpression of this transcription factor plays a critical role in this tumor type.

  • Identifying post-menopausal women at elevated risk for epithelial ovarian cancer

    2015, Gynecologic Oncology
    Citation Excerpt :

    The addition of BSOR to hysterectomy in women who do not carry BRCA1/2 mutations was recently reported to show no negative effects on ovarian function or perioperative complications [8,11]. Efficacy of this approach remains to be demonstrated [12]. Post-menopausal women having hysterectomy for benign conditions must choose among prophylactic BSO, prophylactic BSOR, or retention of both ovaries and fallopian tubes.

  • The postreproductive salpingectomy

    2014, Fertility and Sterility
View all citing articles on Scopus
View full text